Study record

Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction

Liao Y, Xu J, Jiao Y et al. · Biomedicines · 2026

AnimalSeveralEvidence tier CAlso: Human observationalAlso: Cell study (in vitro)

What this study reported

Measured lower humanin and MOTS-c in human atrial tissue in atrial fibrillation, with levels inversely correlated with fibrosis extent, and lower plasma MOTS-c in patients that was inversely correlated with NT-proBNP. Reported that in angiotensin II-exposed mice, administered MOTS-c or a humanin analogue was associated with lower atrial fibrillation inducibility, less fibrosis and hypertrophy and improved mitochondrial ultrastructure, and that both peptides reduced angiotensin II-induced fibroblast activation in culture.

Limitations

Small matched human cohort with cross-sectional sampling; male mice only; RNA-seq findings described as exploratory and not validated.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Specieshuman, mouse, rat
System studiedHuman atrial tissue and plasma in atrial fibrillation; angiotensin II mouse atrial fibrillation model; primary rat cardiomyocytes and fibroblasts
Populationpatients with atrial fibrillation and matched sinus rhythm controls
DesignCase-control measurement with controlled animal and cell experiments
Sample size as reported39 patients with atrial fibrillation and 39 sinus rhythm controls; 36 male mice
Control groupsinus rhythm controls; vehicle-treated angiotensin II animals and cells
Route (data field only)Not reported
Endpoints measuredatrial humanin and MOTS-c expression; plasma MOTS-c; atrial fibrillation inducibility; atrial fibrosis and hypertrophy; mitochondrial ultrastructure and fission proteins; pro-inflammatory cytokines
Pathways measuredTGF-β / SMAD · Inflammation · Oxidative stress · Other
Research areasCardiovascular · Mitochondrial biology · Inflammation & immunity
Evidence tierC — Animal in vivo
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.